Study of How Atezolizumab and Bevacizumab Affects the Tumors of Liver Cancer or Lung Cancer With Liver Metastases

Conditions:   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer Metastatic;   Liver Metastases Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab Sponsors:   University Health Network, Toronto;   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials